IO Biotech Inc’s recently made public that its Director Hunter Heidi acquired Company’s shares for reported $20884.0 on May 30 ’25. In the deal valued at $1.39 per share,15,000 shares were bought. As a result of this transaction, Hunter Heidi now holds 15,000 shares worth roughly $9600.0.
Then, Ahmad Qasim Iftikhar bought 31,350 shares, generating $26,553 in total proceeds. Upon buying the shares at $0.85, the Chief Medical Officer now owns 31,350 shares.
Before that, Zocca Mai-Britt bought 12,500 shares. IO Biotech Inc shares valued at $10,120 were divested by the Chief Executive Officer at a price of $0.81 per share. As a result of the transaction, Zocca Mai-Britt now holds 49,891 shares, worth roughly $31930.24.
TD Cowen downgraded its IO Biotech Inc [IOBT] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who decreased its forecast for the stock in late September from “an Overweight” to “an Equal-weight”.
Price Performance Review of IOBT
On Tuesday, IO Biotech Inc [NASDAQ:IOBT] saw its stock jump 10.52% to $0.64. Over the last five days, the stock has gained 24.72%. IO Biotech Inc shares have fallen nearly -37.69% since the year began. Nevertheless, the stocks have fallen -30.24% over the past one year.
How much short interest is there in IO Biotech Inc?
A steep rise in short interest was recorded in IO Biotech Inc stocks on 2025-09-30, growing by 1.1 million shares to a total of 2.33 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-29 was 1.23 million shares. There was a rise of 47.25%, which implies that there is a positive sentiment for the stock.
